Recent Advances in the Development of Hybrid Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Advances in the Development of Hybrid Drugs

Published:2024-07-01 Issue:7 Volume:16 Page:889
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Morais Tânia S.¹²^ORCID

Affiliation:

1. Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal

2. Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal

Abstract

In the search for innovative, selective, effective, and safer treatment strategies, hybrid drugs have gained worldwide momentum [...]

Funder

Fundação para a Ciência e Tecnologia

FCT POPH and FSE-European Social Funds

Publisher

MDPI AG

Link

https://www.mdpi.com/1999-4923/16/7/889/pdf

Reference40 articles.

1. Szumilak, M., Wiktorowska-Owczarek, A., and Stanczak, A. (2021). Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?. Molecules, 26.

2. Singh, A.K., Kumar, A., Singh, H., Sonawane, P., Paliwal, H., Thareja, S., Pathak, P., Grishina, M., Jaremko, M., and Emwas, A.H. (2022). Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals, 15.

3. Therapeutic Significance of Molecular Hybrids for Breast Cancer Research and Treatment;Shagufta;RSC Med. Chem.,2023

4. Emerging Small Molecule-Engineered Hybrid Nanomedicines for Cancer Therapy;Chen;Chem. Eng. J.,2022

5. Peter, S., and Aderibigbe, B.A. (2023). Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents. Molecules, 28.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP